Company / Operating Cash Flow per Share
Moderna Operating Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$4.85
FY2025
5-year range
-$8.10 / $5.03
FY2021-FY2025
Trend
+38.3%
vs FY2024
Sector context
#196 of 212
Health Care
What the data says
Among 212 Health Care companies, Moderna is in the bottom 8% for operating cash flow per share. Operating Cash Flow per Share has fluctuated over the past 10 years, ranging from $-8.10 in FY2023 to $6.02 in FY2020.
Based on SEC 10-K filings.
-4.85 in FY2025.
Improved from $-8.10 to $-4.85 over the past 2 years.
Health Care sector context is included.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 8% in Health CareTop 92% of 212This company -$4.85 Sector average -$14.72
▼
+67.0% above sector average
Key checks
Key Insights
- In FY2025, operating cash flow per share increased 38.3% year-over-year.
- Ranks #196 out of 212 companies in the Health Care sector.
- Peak operating cash flow per share was recorded in FY2020.
- Lowest operating cash flow per share in the period was in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 1.13 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$4.85 | +38.3% |
| FY2024 | -$7.86 | +2.9% |
| FY2023 | -$8.10 | -261.0% |
| FY2022 | $5.03 | +537.2% |
| FY2021 | -$1.15 | -119.1% |
| FY2020 | $6.02 | +531.5% |
| FY2019 | -$1.40 | +72.5% |
| FY2018 | -$5.07 | +1.3% |
| FY2017 | -$5.14 | -567.8% |
| FY2016 | $1.10 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026